Menu
Back to Journals » Drug, Healthcare and Patient Safety » Volume 8
Review
Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 15,884 | Dovepress* | 14,189+ | 2,374 | 16,563 | |
| PubMed Central* | 1,695 | 483 | 2,178 | ||
| Totals | 15,884 | 2,857 | 18,741 | ||
|
*Since 3 February 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar